| Application no. and date | 12721507.7 (espacenet) (Federated) (European Patent Register), 20120511 | | Patent/reg. no. and date | DK/EP 2706982, 20180103 | | Publication date | 20140319 | | Priority no. and date | EP 11166076, 20110513 | | EP pub. no. and date |
EP 2706982 20140319 | | Effective date | | | Applicant/owner | EURO-CELTIQUE S.A., 1, rue Jean Piret
2350 Luxembourg, LU | | Applicant ref. no. | P63873DK01 | | Inventor | STRANG, John, c/o National Addiction Centre
Addiction Sciences Building
4 Windsor Walk
Denmark Hill
London SE5 8AF, GB,
HARRIS, Stephen, c/o Purdue Pharma L. P.
One Stamford Forum
201 Tresser Boulevard
Stamford
Connecticut 06901-3431, US,
SMITH, Kevin, c/o Mundipharma Research Limited
Cambridge Science Park
Milton Road
Cambridge CB4 0GW, GB,
MOTTIER, Lucie Helene Jeanne, c/o Mundipharma Research Limited
Cambridge Science Park
Milton Road
Cambridge CB4 0GW, GB,
OKSCHE, Alexander, c/o Mundipharma GmbH
Mundipharma StraÃYe 2
65549 Limburg, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/135 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 25/36 (2006.01) | | Title | INTRANASALE FARMACEUTISKE DOSISFORMER OMFATTENDE NALOXON | | Int. application no. | EP2012058792 | | Int. publication no. | WO2012156317 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
